Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
Aditi Shirsat,1 Siddhi Pashilkar,2 Ashish Chavan,1 Devanshi Kalra,2 Vikram Gota,1,3 Amit Joshi,2,3 Manjunath Nookala Krishnamurthy1,3 1Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India; 2Departme...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6950c31bdf904c32aff377dd522dc393 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6950c31bdf904c32aff377dd522dc393 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6950c31bdf904c32aff377dd522dc3932021-11-18T19:40:25ZEffect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients1178-6981https://doaj.org/article/6950c31bdf904c32aff377dd522dc3932021-11-01T00:00:00Zhttps://www.dovepress.com/effect-of-the-pandemic-on-quality-of-life-data-collection-in-prostate--peer-reviewed-fulltext-article-CEORhttps://doaj.org/toc/1178-6981Aditi Shirsat,1 Siddhi Pashilkar,2 Ashish Chavan,1 Devanshi Kalra,2 Vikram Gota,1,3 Amit Joshi,2,3 Manjunath Nookala Krishnamurthy1,3 1Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India; 2Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India; 3Homi Bhabha National Institute, Mumbai, Maharashtra, IndiaCorrespondence: Manjunath Nookala KrishnamurthyDepartment of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector- 22, Kharghar, Navi Mumbai, 410210, Maharashtra, IndiaTel +91 2268735130Email mnookala@actrec.gov.in; nk.manjunath@gmail.comPurpose: To understand the difficulties that happen during the quality of life (QoL) data collection in a pandemic and provide measures to overcome them.Methods: We analyzed the recruitment and follow-up data of patients in one of our ongoing study whose aim was to collect the Adverse drug reactions and QoL (at regular intervals) in prostate cancer patients who were on docetaxel. Before the pandemic, we could enroll 31 patients in the study over four months. We analyzed the difficulties experienced by these patients and consultants in collecting QoL data during the pandemic, especially in situations with limited availability of resources and also where the patients are not technologically advanced.Results: Due to the pandemic, we could not recruit a single new patient into the study. Complete QoL assessments were available in only two patients, and the disease progressed in five patients. QoL assessment was not possible in 19 of 31 enrolled patients. More than 44% of the enrolled patients had difficulty commuting to the hospital despite transport services to hospitals. Due to the risk of acquiring COVID19 infection during traveling to the hospital, follow-ups were affected.Conclusion: There should be increased support for novel technologies that can successfully capture and transfer patients’ QoL data to the treating consultant.Keywords: pandemic, coronavirus, quality of life, COVID 19Shirsat APashilkar SChavan AKalra DGota VJoshi ANookala Krishnamurthy MDove Medical Pressarticlepandemiccoronavirusquality of lifecovid 19Medicine (General)R5-920Therapeutics. PharmacologyRM1-950ENClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 937-941 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
pandemic coronavirus quality of life covid 19 Medicine (General) R5-920 Therapeutics. Pharmacology RM1-950 |
spellingShingle |
pandemic coronavirus quality of life covid 19 Medicine (General) R5-920 Therapeutics. Pharmacology RM1-950 Shirsat A Pashilkar S Chavan A Kalra D Gota V Joshi A Nookala Krishnamurthy M Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients |
description |
Aditi Shirsat,1 Siddhi Pashilkar,2 Ashish Chavan,1 Devanshi Kalra,2 Vikram Gota,1,3 Amit Joshi,2,3 Manjunath Nookala Krishnamurthy1,3 1Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India; 2Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India; 3Homi Bhabha National Institute, Mumbai, Maharashtra, IndiaCorrespondence: Manjunath Nookala KrishnamurthyDepartment of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector- 22, Kharghar, Navi Mumbai, 410210, Maharashtra, IndiaTel +91 2268735130Email mnookala@actrec.gov.in; nk.manjunath@gmail.comPurpose: To understand the difficulties that happen during the quality of life (QoL) data collection in a pandemic and provide measures to overcome them.Methods: We analyzed the recruitment and follow-up data of patients in one of our ongoing study whose aim was to collect the Adverse drug reactions and QoL (at regular intervals) in prostate cancer patients who were on docetaxel. Before the pandemic, we could enroll 31 patients in the study over four months. We analyzed the difficulties experienced by these patients and consultants in collecting QoL data during the pandemic, especially in situations with limited availability of resources and also where the patients are not technologically advanced.Results: Due to the pandemic, we could not recruit a single new patient into the study. Complete QoL assessments were available in only two patients, and the disease progressed in five patients. QoL assessment was not possible in 19 of 31 enrolled patients. More than 44% of the enrolled patients had difficulty commuting to the hospital despite transport services to hospitals. Due to the risk of acquiring COVID19 infection during traveling to the hospital, follow-ups were affected.Conclusion: There should be increased support for novel technologies that can successfully capture and transfer patients’ QoL data to the treating consultant.Keywords: pandemic, coronavirus, quality of life, COVID 19 |
format |
article |
author |
Shirsat A Pashilkar S Chavan A Kalra D Gota V Joshi A Nookala Krishnamurthy M |
author_facet |
Shirsat A Pashilkar S Chavan A Kalra D Gota V Joshi A Nookala Krishnamurthy M |
author_sort |
Shirsat A |
title |
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients |
title_short |
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients |
title_full |
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients |
title_fullStr |
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients |
title_full_unstemmed |
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients |
title_sort |
effect of the pandemic on quality-of-life data collection in prostate cancer patients |
publisher |
Dove Medical Press |
publishDate |
2021 |
url |
https://doaj.org/article/6950c31bdf904c32aff377dd522dc393 |
work_keys_str_mv |
AT shirsata effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients AT pashilkars effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients AT chavana effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients AT kalrad effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients AT gotav effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients AT joshia effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients AT nookalakrishnamurthym effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients |
_version_ |
1718420731919859712 |